Literature DB >> 23380084

Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice.

Purna C Kashyap1, Angela Marcobal, Luke K Ursell, Muriel Larauche, Henri Duboc, Kristen A Earle, Erica D Sonnenburg, Jessica A Ferreyra, Steven K Higginbottom, Mulugeta Million, Yvette Tache, Pankaj J Pasricha, Rob Knight, Gianrico Farrugia, Justin L Sonnenburg.   

Abstract

BACKGROUND & AIMS: Diet has major effects on the intestinal microbiota, but the exact mechanisms that alter complex microbial communities have been difficult to elucidate. In addition to the direct influence that diet exerts on microbes, changes in microbiota composition and function can alter host functions such as gastrointestinal (GI) transit time, which in turn can further affect the microbiota.
METHODS: We investigated the relationships among diet, GI motility, and the intestinal microbiota using mice that are germ-free (GF) or humanized (ex-GF mice colonized with human fecal microbiota).
RESULTS: Analysis of gut motility revealed that humanized mice fed a standard polysaccharide-rich diet had faster GI transit and increased colonic contractility compared with GF mice. Humanized mice with faster transit due to administration of polyethylene glycol or a nonfermentable cellulose-based diet had similar changes in gut microbiota composition, indicating that diet can modify GI transit, which then affects the composition of the microbial community. However, altered transit in mice fed a diet of fermentable fructooligosaccharide indicates that diet can change gut microbial function, which can affect GI transit.
CONCLUSIONS: Based on studies in humanized mice, diet can affect GI transit through microbiota-dependent or microbiota-independent pathways, depending on the type of dietary change. The effect of the microbiota on transit largely depends on the amount and type (fermentable vs nonfermentable) of polysaccharides present in the diet. These results have implications for disorders that affect GI transit and gut microbial communities, including irritable bowel syndrome and inflammatory bowel disease.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380084      PMCID: PMC3890323          DOI: 10.1053/j.gastro.2013.01.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  Gut microbiota in health and disease.

Authors:  Inna Sekirov; Shannon L Russell; L Caetano M Antunes; B Brett Finlay
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 2.  Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea.

Authors:  Michael Camilleri; Sara Nullens; Tyler Nelsen
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

Review 3.  Host-bacterial mutualism in the human intestine.

Authors:  Fredrik Bäckhed; Ruth E Ley; Justin L Sonnenburg; Daniel A Peterson; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

4.  The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice.

Authors:  Peter J Turnbaugh; Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Rob Knight; Jeffrey I Gordon
Journal:  Sci Transl Med       Date:  2009-11-11       Impact factor: 17.956

Review 5.  Microbial ecology of the gastrointestinal tract.

Authors:  D C Savage
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

6.  Glycan foraging in vivo by an intestine-adapted bacterial symbiont.

Authors:  Justin L Sonnenburg; Jian Xu; Douglas D Leip; Chien-Huan Chen; Benjamin P Westover; Jeremy Weatherford; Jeremy D Buhler; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 7.  Bacterial overgrowth of the gastrointestinal tract.

Authors:  P P Toskes
Journal:  Adv Intern Med       Date:  1993

Review 8.  The intestinal microbiota and chronic disorders of the gut.

Authors:  Andrew W DuPont; Herbert L DuPont
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-16       Impact factor: 46.802

9.  Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors.

Authors:  G Gourcerol; L Wang; D W Adelson; M Larauche; Y Taché; M Million
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

10.  Identifying genomic and metabolic features that can underlie early successional and opportunistic lifestyles of human gut symbionts.

Authors:  Catherine Lozupone; Karoline Faust; Jeroen Raes; Jeremiah J Faith; Daniel N Frank; Jesse Zaneveld; Jeffrey I Gordon; Rob Knight
Journal:  Genome Res       Date:  2012-06-04       Impact factor: 9.043

View more
  158 in total

1.  Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates.

Authors:  Erica D Sonnenburg; Justin L Sonnenburg
Journal:  Cell Metab       Date:  2014-08-21       Impact factor: 27.287

2.  Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine.

Authors:  Weiwei Lei; Wenwen Ren; Makoto Ohmoto; Joseph F Urban; Ichiro Matsumoto; Robert F Margolskee; Peihua Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

3.  Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production.

Authors:  Yogesh Bhattarai; Bradley A Schmidt; David R Linden; Eric D Larson; Madhusudan Grover; Arthur Beyder; Gianrico Farrugia; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-13       Impact factor: 4.052

4.  Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.

Authors:  Rachel M Presti; Scott A Handley; Lindsay Droit; Mahmoud Ghannoum; Mark Jacobson; Caroline H Shiboski; Jennifer Webster-Cyriaque; Todd Brown; Michael T Yin; Edgar T Overton
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

Review 5.  Recommendations for evaluation of bladder and bowel function in pre-clinical spinal cord injury research.

Authors:  Gregory M Holmes; Charles H Hubscher; Andrei Krassioukov; Lyn B Jakeman; Naomi Kleitman
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

6.  High-fat diet-induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy.

Authors:  Yvonne Nyavor; Catherine R Brands; George May; Sydney Kuther; Jessica Nicholson; Kathryn Tiger; Abigail Tesnohlidek; Allysha Yasuda; Kiefer Starks; Diana Litvinenko; David R Linden; Yogesh Bhattarai; Purna C Kashyap; Larry J Forney; Onesmo B Balemba
Journal:  Neurogastroenterol Motil       Date:  2020-03-13       Impact factor: 3.598

7.  The tuning of the gut nervous system by commensal microbiota.

Authors:  Nobuhiko Kamada; John Y Kao
Journal:  Gastroenterology       Date:  2013-12       Impact factor: 22.682

Review 8.  Control of commensal microbiota by the adaptive immune system.

Authors:  Husen Zhang; Xin M Luo
Journal:  Gut Microbes       Date:  2015

9.  Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.

Authors:  Jessica A Ferreyra; Katherine J Wu; Andrew J Hryckowian; Donna M Bouley; Bart C Weimer; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2014-12-10       Impact factor: 21.023

10.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.